Literature DB >> 11912996

Early intervention in massive pulmonary embolism. A guide to diagnosis and triage for the critical first hour.

James R Gossage1.   

Abstract

The diagnosis of massive pulmonary embolism should be considered expeditiously in all patients with unexplained hypotension, syncope, cardiac arrest, or hypoxemic respiratory failure. The presence of right ventricular overload on physical examination or electrocardiogram is an especially important clue. Depending on local expertise and the patient's stability, V/Q scanning, CT angiography, echocardiography, and right heart catheterization can be useful in establishing a diagnosis of pulmonary embolism. Supportive treatment includes oxygen, vasoactive medicines, and sometimes fluids. Although heparin is important in nearly all patients, 70% to 80% of patients also require an IVC filter, thrombolysis, or embolectomy.

Entities:  

Mesh:

Year:  2002        PMID: 11912996     DOI: 10.3810/pgm.2002.03.1131

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

1.  Caution for acute submassive pulmonary embolism with syncope as initial symptom: a case report.

Authors:  Sheng-Yu Wang; Hui Chen; Li-Gai Di
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Authors:  Harry Messmore; Walter Jeske; William Wehrmacher; Jeanine Walenga
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Agnogenic massive pulmonary embolism with syncope as initial symptom: A case report and review of the literature.

Authors:  Ai-Gui Jiang; Hui-Yu Lu
Journal:  Exp Ther Med       Date:  2013-03-07       Impact factor: 2.447

4.  Subacute combined degeneration of the spinal cord concurrent with acute pulmonary embolism: a case report.

Authors:  Xinyuan Pang; Yulei Hao; Lushun Ma; Lu Liu; Jiachun Feng
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.